Literature DB >> 25971330

Efficacy of amoxycillin and clarithromycin-based triple therapy for Helicobacter pylori eradication: a 10-year trend in Turin, Italy.

D G Ribaldone1, S Fagoonee, M Astegiano, G Saracco, R Pellicano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25971330

Source DB:  PubMed          Journal:  Panminerva Med        ISSN： 0031-0808            Impact factor:   5.197


× No keyword cloud information.
  5 in total

1.  Microscopic colitis in patients with mild duodenal damage: A new clinical and pathological entity ("lymphocytic enterocolitis")?

Authors:  Gabriele Antonio Bonagura; Davide Giuseppe Ribaldone; Sharmila Fagoonee; Nicoletta Sapone; Gian Paolo Caviglia; Giorgio Maria Saracco; Marco Astegiano; Rinaldo Pellicano
Journal:  World J Gastrointest Pathophysiol       Date:  2016-11-15

2.  Finally, it is bismuth's time.

Authors:  Davide G Ribaldone; Giorgio Saracco; Rinaldo Pellicano
Journal:  Saudi J Gastroenterol       Date:  2017 Mar-Apr       Impact factor: 2.485

3.  Response to: Reply on "Renewed Helicobacter pylori management and therapy in 2015".

Authors:  Sharmila Fagoonee; Rinaldo Pellicano
Journal:  Saudi J Gastroenterol       Date:  2016 Jan-Feb       Impact factor: 2.485

4.  One or two weeks of treatment with Helicobacter Pylori ''standard'' triple therapy in the year 2015?

Authors:  Rinaldo Pellicano; Sharmila Fagoonee
Journal:  Saudi J Gastroenterol       Date:  2015 Nov-Dec       Impact factor: 2.485

5.  Two-week triple therapy has a higher Helicobacter pylori eradication rate than 1-week therapy: A single-center randomized study.

Authors:  Jiaofeng Wang; Gansheng Zhang; Xiaona Hu; Ye Liu; Zhijun Bao; Yiqin Huang
Journal:  Saudi J Gastroenterol       Date:  2015 Nov-Dec       Impact factor: 2.485
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.